340 related articles for article (PubMed ID: 32146898)
1. Rates of Potentially Inappropriate Dosing of Direct-Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE-AF Study.
Sanghai S; Wong C; Wang Z; Clive P; Tran W; Waring M; Goldberg R; Hayward R; Saczynski JS; McManus DD
J Am Heart Assoc; 2020 Mar; 9(6):e014108. PubMed ID: 32146898
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of the Direct Oral Anticoagulants Dosing in the Middle East Gulf Region.
Anouassi Z; Atallah B; Alsoud LO; El Nekidy W; Al Mahmeed W; AlJaabari M; Almuti K
J Cardiovasc Pharmacol; 2021 Feb; 77(2):182-188. PubMed ID: 32925474
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
[TBL] [Abstract][Full Text] [Related]
4. Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.
Saczynski JS; Sanghai SR; Kiefe CI; Lessard D; Marino F; Waring ME; Parish D; Helm R; Sogade F; Goldberg R; Gurwitz J; Wang W; Mailhot T; Bamgbade B; Barton B; McManus DD
J Am Geriatr Soc; 2020 Jan; 68(1):147-154. PubMed ID: 31574165
[TBL] [Abstract][Full Text] [Related]
5. Appropriateness of direct oral anticoagulant prescribing in older subjects with atrial fibrillation discharged from acute medical wards.
De Vincentis A; Soraci L; Arena E; Sciacqua A; Armentaro G; Aucella F; Corsonello A; Aucella F; Antonelli Incalzi R
Br J Clin Pharmacol; 2024 May; 90(5):1231-1239. PubMed ID: 38321367
[TBL] [Abstract][Full Text] [Related]
6. Use of Direct Oral Anticoagulants in Canadian Primary Care Practice 2010-2015: A Cohort Study From the Canadian Primary Care Sentinel Surveillance Network.
McAlister FA; Garrison S; Kosowan L; Ezekowitz JA; Singer A
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374047
[TBL] [Abstract][Full Text] [Related]
7. PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study.
Kocabaş U; Ergin I; Yavuz V; Murat S; Özdemir I; Genç Ö; Altın C; Tüner H; Meriç BK; Çoner A; Yüce Eİ; Boyraz B; Aslan O; Dal A; Şen T; İbişoğlu E; Erdoğan A; Özgeyik M; Demir M; Bilgel ZG; Şengör BG; Urgun ÖD; Doğduş M; Tekin DDN; Çakal S; Çayırlı S; Güler A; Karabulut D; Dalgıç O; Uzman O; Murat B; Şahin Ş; Karabulut U; Kıvrak T; Coşgun MS; Özyurtlu F; Kaplan M; Özçalık E;
Cardiovasc Drugs Ther; 2024 Jun; 38(3):581-599. PubMed ID: 36527566
[TBL] [Abstract][Full Text] [Related]
8. Initial apixaban dosing in patients with atrial fibrillation.
Buchholz A; Ueberham L; Gorczynska K; Dinov B; Hilbert S; Dagres N; Husser D; Hindricks G; Bollmann A
Clin Cardiol; 2018 May; 41(5):671-676. PubMed ID: 29542830
[TBL] [Abstract][Full Text] [Related]
9. Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation.
Yu HT; Yang PS; Jang E; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
J Am Heart Assoc; 2020 Jun; 9(12):e014177. PubMed ID: 32495677
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate Dosing of Direct Oral Anticoagulants in Patients with Atrial Fibrillation.
Sugrue A; Sanborn D; Amin M; Farwati M; Sridhar H; Ahmed A; Mehta R; Siontis KC; Mulpuru SK; Deshmukh AJ; Gersh BJ; Asirvatham SJ; Madhavan M
Am J Cardiol; 2021 Apr; 144():52-59. PubMed ID: 33385355
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses.
Briasoulis A; Gao Y; Inampudi C; Alvarez P; Asleh R; Chrischilles E; Leira EC; Vaughan-Sarrazin M
BMC Cardiovasc Disord; 2020 Feb; 20(1):42. PubMed ID: 32013886
[TBL] [Abstract][Full Text] [Related]
12. Factors Associated With the Choice of Oral Anticoagulant Class in the Older Patients: An Observational Study.
Pagès A; Sabatier R; Sallerin B
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):332-337. PubMed ID: 32266832
[TBL] [Abstract][Full Text] [Related]
13. Inappropriate direct oral anticoagulant prescriptions in patients with non-valvular atrial fibrillation: cross-sectional analysis of the French CACAO cohort study in primary care.
Ferrat E; Fabre J; Galletout P; Boutin E; Le Breton J; Renard V; Frappé P; Bastuji-Garin S
Br J Gen Pract; 2021; 71(703):e134-e139. PubMed ID: 33495204
[TBL] [Abstract][Full Text] [Related]
14. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF.
Guenoun M; Cohen S; Villaceque M; Sharareh A; Schwartz J; Hoffman O; Dib JC; Ouazana L; Assouline S; Parrens E; Garban T; Pradeau V; Guedj-Meynier D; Lequeux B; Cohen C; Durand P; Dievart F; Dhanjal TS; Sabouret P; Lellouche N
Europace; 2023 Oct; 25(10):. PubMed ID: 37801642
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
17. Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial Fibrillation.
Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Peterson GM
J Patient Saf; 2022 Jun; 18(4):337-341. PubMed ID: 35617592
[TBL] [Abstract][Full Text] [Related]
18. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
Steinberg BA; Shrader P; Pieper K; Thomas L; Allen LA; Ansell J; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli GV; Reiffel JA; Singer DE; Peterson ED; Piccini JP;
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29453305
[TBL] [Abstract][Full Text] [Related]
19. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
20. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
